Invitation to participate in 2nd phase of systematic reviews
We are approaching the next phase for WG1 systematic reviews on 1) risk of developing COVID-19 for people with cancer, 2) risk of death after developing COVID-19 for people with cancer and 3)smoking and other cancer risk behaviour changes during the COVID-19 pandemic, and are seeking expressions of interest from any early-career researchers who would like to be involved and undertake title and abstract screening and/or article full text screening and/or data extraction. We are also seeking expressions of interest from any experienced systematic reviewers or senior researchers to help with coordinating and overseeing this process. If you would like to be involved in this piece of work, please kindly complete the following form by end of April to indicate how you would wish to contribute, your level of experience and availability.
Working Group 3
Kindly complete this survey to inform Working Group 3 of any on-going or planned surveys you are aware of that may capture the impact of COVID-19 on cancer risk factors (e.g. smoking, alcohol, bodyweight, physical inactivity, diet).
These surveys may be targeted surveys that ask explicitly about behaviour changes during the pandemic, or any regular surveys or cohort studies that would have information on behaviour before and during the pandemic, so we can assess any differences. These surveys can be nation-wide or of sub-national jurisdictions.
Upcoming events
ICSN Webinar: COVID-19 and Cancer Screening
The ICSN webinar will be held on 10th May 2021, 18:00h-19:00h, Central European Time. The webinar will focus on the results of the ICSN survey assessing the effects of the first wave of COVID-19 on cancer screening around the world. Douglas Puricelli Perin, MPH, ICSN Program Coordinator, will present the results of the ICSN survey together with a literature review about the disruptions in cancer screening caused by previous disasters. In addition, Iris Lansdorp-Vogelaar, PhD, Associate Professor at the Department of Public Health of Erasmus Medical Center, will present the latest developments with the COVID-19 and Cancer Global Modelling Consortium.
News and Announcements
Working Group 1
Invitation to participate in 2nd phase of systematic reviews
We are approaching the next phase for WG1 systematic reviews on 1) risk of developing COVID-19 for people with cancer, 2) risk of death after developing COVID-19 for people with cancer and 3)smoking and other cancer risk behaviour changes during the COVID-19 pandemic, and are seeking expressions of interest from any early-career researchers who would like to be involved and undertake title and abstract screening and/or article full text screening and/or data extraction. We are also seeking expressions of interest from any experienced systematic reviewers or senior researchers to help with coordinating and overseeing this process. If you would like to be involved in this piece of work, please kindly complete the following form by end of April to indicate how you would wish to contribute, your level of experience and availability.
Working Group 3
Kindly complete this survey to inform Working Group 3 of any on-going or planned surveys you are aware of that may capture the impact of COVID-19 on cancer risk factors (e.g. smoking, alcohol, bodyweight, physical inactivity, diet).
These surveys may be targeted surveys that ask explicitly about behaviour changes during the pandemic, or any regular surveys or cohort studies that would have information on behaviour before and during the pandemic, so we can assess any differences. These surveys can be nation-wide or of sub-national jurisdictions.
Upcoming events
ICSN Webinar: COVID-19 and Cancer Screening
The ICSN webinar will be held on 10th May 2021, 18:00h-19:00h, Central European Time. The webinar will focus on the results of the ICSN survey assessing the effects of the first wave of COVID-19 on cancer screening around the world. Douglas Puricelli Perin, MPH, ICSN Program Coordinator, will present the results of the ICSN survey together with a literature review about the disruptions in cancer screening caused by previous disasters. In addition, Iris Lansdorp-Vogelaar, PhD, Associate Professor at the Department of Public Health of Erasmus Medical Center, will present the latest developments with the COVID-19 and Cancer Global Modelling Consortium.
Please follow this link to register.
Terms of Reference
The Terms of Reference for the Consortium have now been confirmed. Download the Terms of Reference